文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

美国国立卫生研究院共识发展会议声明:40 - 49岁女性乳腺癌筛查,1997年1月21 - 23日。美国国立卫生研究院共识发展小组。

National Institutes of Health Consensus Development Conference Statement: breast cancer screening for women ages 40-49, January 21-23, 1997. National Institutes of Health Consensus Developmental Panel.

出版信息

J Natl Cancer Inst Monogr. 1997(22):vii-xviii.


DOI:
PMID:9709265
Abstract

OBJECTIVE: To provide heatlh care providers, patients, and the general public with a responsible assessment of currently available data regarding the effectiveness of mammography screening for women ages 40-49. PARTICIPANTS: A non-Federal, nonadvocate, 12-member panel representing the fields of oncology, radiology, obstetrics and gynecology, geriatrics, public health, and epidemiology and including patient representatives. In addition, 32 experts in oncology, surgical oncology, radiology, public health, and epidemiology, presented data to the panel and to a conference audience of 1,100. EVIDENCE: The literature was searched through Medline and an extensive bibliography of references was provided to the panel and the conference audience. Experts prepared abstracts with relevant citations from the literature. Scientific evidence was given precedence over clinical anecdotal experience. CONSENSUS PROCESS: The panel, answering predefined questions, developed its conclusions based on the scientific evidence presented in open forum and the scientific literature. The panel composed a draft statement that was read in its entirety and circulated to the experts and the audience for comment. Thereafter, the panel resolved conflicting recommendations and released a revised draft statement at the end of the conference. The final statement with a minority report was completed within several weeks after the conference. CONCLUSIONS: The Panel concludes that the data currently available do not warrant a universal recommendation for mammography for all women in their forties. Each woman should decide for herself whether to undergo mammography. Her decision may be based not only on an objective analysis of the scientific evidence and consideration of her individual medical history, but also on how she perceives and weighs each potential risk and benefit, the values she places on each, and how she deals with uncertainty. However, it is not sufficient just to advise a woman to make her own decision about mammograms. Given both the importance and the complexity of the issues involved in assessing the evidence, a woman should have access to the best possible relevant information regarding both benefits and risks, presented in an understandable and usable form. Information should be developed for women in their forties regarding potential benefits and risks to be provided to enable each woman to make the most appropriate decision. In addition, educational material to accompany this information should be prepared that will lead women step by step through the process of using such information in the best possible way for reaching a decision. For women in their forties who choose to have mammography performed, the costs of the mammograms should be reimbursed by third-party payors or covered by health maintenance organizations so that financial impediments will not influence a woman's decision. Additionally, a woman's health care provider must be equipped with sufficient information to facilitate her decisionmaking process. Therefore, educational material for physicians should be developed to assist them in providing the guidance and support needed by the women in their care who are making difficult decisions regarding mammography. The two panel members writing a minority report believed the risks of mammography to be overemphasized by the majority and concluded that the data did support a recommendation for mammography screening for all women in this age group and that the survival benefit and diagnosis at an earlier stage outweigh the potential risks.

摘要

目的:为医疗保健提供者、患者及公众提供关于40至49岁女性乳房X线筛查有效性的现有数据的负责任评估。 参与者:一个由12名成员组成的非联邦、无党派小组,代表肿瘤学、放射学、妇产科、老年医学、公共卫生和流行病学领域,包括患者代表。此外,32名肿瘤学、外科肿瘤学、放射学、公共卫生和流行病学专家向该小组及1100名参会人员提供了数据。 证据:通过医学文献数据库检索文献,并向该小组及参会人员提供了广泛的参考文献目录。专家们编写了带有文献相关引用的摘要。科学证据优先于临床轶事经验。 共识形成过程:该小组回答预先设定的问题,根据公开论坛上呈现的科学证据和科学文献得出结论。该小组撰写了一份声明草案,全文宣读并分发给专家和参会人员征求意见。此后,该小组解决了相互冲突的建议,并在会议结束时发布了一份修订后的声明草案。会议结束后的几周内完成了带有少数派报告的最终声明。 结论:该小组得出结论,目前可得的数据并不足以支持对所有40多岁的女性普遍推荐进行乳房X线检查。每位女性应自行决定是否接受乳房X线检查。她的决定不仅可以基于对科学证据的客观分析以及对其个人病史的考虑,还可以基于她如何看待和权衡每个潜在的风险与益处、她对每个方面所赋予的价值以及她如何应对不确定性。然而,仅仅建议女性自行决定是否进行乳房X线检查是不够的。鉴于评估证据所涉及问题的重要性和复杂性,女性应能够以易懂且可用的形式获取关于益处和风险的尽可能最佳的相关信息。应针对40多岁的女性制定有关潜在益处和风险的信息,以便每位女性能够做出最恰当的决定。此外,应编写与此信息配套的教育材料,逐步引导女性以最佳方式利用此类信息来做出决定。对于选择进行乳房X线检查的40多岁女性,乳房X线检查的费用应由第三方支付者报销或由健康维护组织承担,以使经济障碍不会影响女性的决定。此外,女性的医疗保健提供者必须具备足够的信息,以促进其决策过程。因此,应为医生编写教育材料,以协助他们为在护理过程中就乳房X线检查做出艰难决定的女性提供所需的指导和支持。撰写少数派报告的两名小组成员认为多数派过度强调了乳房X线检查的风险,并得出结论认为数据确实支持对该年龄组所有女性进行乳房X线筛查的建议,且生存益处和早期诊断超过了潜在风险。

相似文献

[1]
National Institutes of Health Consensus Development Conference Statement: breast cancer screening for women ages 40-49, January 21-23, 1997. National Institutes of Health Consensus Developmental Panel.

J Natl Cancer Inst Monogr. 1997

[2]
NIH Consensus Statement. Breast cancer screening for women ages 40-49.

NIH Consens Statement. 1997

[3]
National Institutes of Health Consensus Development Conference Statement: Breast Cancer Screening for Women Ages 40-49, January 21-23, 1997. National Institutes of Health Consensus Development Panel.

J Natl Cancer Inst. 1997-7-16

[4]
National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.

J Natl Cancer Inst Monogr. 2001

[5]
Adjuvant therapy for breast cancer.

NIH Consens Statement. 2000

[6]
National Institutes of Health Consensus Development Conference Statement: cervical cancer, April 1-3, 1996. National Institutes of Health Consensus Development Panel.

J Natl Cancer Inst Monogr. 1996

[7]
Genetic testing for cystic fibrosis. National Institutes of Health Consensus Development Conference Statement on genetic testing for cystic fibrosis.

Arch Intern Med. 1999-7-26

[8]
Rehabilitation of persons with traumatic brain injury.

NIH Consens Statement. 1998

[9]
Interventions to prevent HIV risk behaviors. National Institutes of Health Consensus Development Conference Statement February 11-13, 1997.

AIDS. 2000-9

[10]
Cervical cancer.

NIH Consens Statement. 1996

引用本文的文献

[1]
Medicolegal implications of accuracy of GP referral letters to specialist breast clinic.

Ir J Med Sci. 2016-2

[2]
Breast cancer knowledge and early detection among Hispanic women with a family history of breast cancer along the U.S.-Mexico border.

J Health Care Poor Underserved. 2010-5

[3]
Recent translational research: computational studies of breast cancer.

Breast Cancer Res. 2005

[4]
Clodronate: a review of its use in breast cancer.

Drugs Aging. 1999-8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索